Levofloxacin
250 mg/50mL · Injection, Solution
- Prescription only
- Active substance
- Levofloxacin
- Made by
- Hikma Pharmaceuticals USA Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Levofloxacin). It describes the substance, not this exact product.
Levofloxacin is a member of the fluoroquinolone class of antibacterial agents [ see Microbiology (12.4)].
Due to the limited extent of levofloxacin metabolism, the pharmacokinetics of levofloxacin are not expected to be affected by hepatic impairment [see Use in Specific Populations ( 8.7 )].
Levofloxacin undergoes limited metabolism in humans and is primarily excreted as unchanged drug in the urine.
Oral administration of a 500 mg dose of levofloxacinwith food prolongs the time to peak concentration by approximately 1 hour and decreases the peak concentration by approximately 14% following tablet and approximately 25% following oral solution administration.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-05-20
Safety of the active substance
From the US prescribing label for the same active substance (Levofloxacin). It describes the substance, not this exact product.
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYASTHENIA GRAVIS.
- Levofloxacin tablets are contraindicated in persons with known hypersensitivity to levofloxacin, or other quinolone antibacterials [ see Warnings and Precautions (5.3 )].
- Known hypersensitivity to levofloxacin or other quinolones ( 4, 5.7 )
The most common reactions (≥3%) were nausea, headache, diarrhea, insomnia, constipation and dizziness (6.2).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Hikma Pharmaceuticals USA Inc. |
|---|---|
| Active substance | Levofloxacin |
| Strength | 250 mg/50mL |
| Form | Injection, Solution |
| Route | Intravenous |
| Packs | 24 BAG in 1 CARTON / 50 mL in 1 BAG |
| NDC | 0143-9315 |
| NDC | 0143-9722 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
98 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Film Coated72 products
- Injection, Solution16 products
5 mg/mL2
5 mg/mL · 2 companies
25 mg/mL2
25 mg/mL · 2 companies
250 mg/50mL4
250 mg/50mL · 4 companies
- Eugia US LLC
- Gland Pharma Limited
- Hikma Pharmaceuticals USA Inc. · this page
- Hospira, Inc
500 mg/100mL4
500 mg/100mL · 4 companies
750 mg/150mL4
750 mg/150mL · 4 companies
- Solution3 products
- 5 mg/mL
25 mg/mL2
25 mg/mL · 2 companies
- Tablet3 products
Show all forms · 7 forms
- Injection, Solution, Concentrate2 products
- Solution/ Drops1 products
- Injection1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.